StonvexLoading…
StonvexStonvexStonvexCore line items from NCMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-01 | Annual 2024 2024-12-26 | Annual 2023 2023-12-28 | Annual 2022 2022-12-29 |
|---|---|---|---|---|
Revenue | $243.20M | $240.80M | $165.20M | $249.20M |
Operating Income | $-13.90M | $-19.50M | $-27.30M | $6.90M |
Net Income | $-10.60M | $-22.30M | $705.20M | $-28.70M |
EPS (Diluted) | $-0.11 | $-0.23 | $14.34 | $-3.50 |
Total Assets | $490.60M | $568.60M | $567.70M | $792.40M |
Total Liabilities | $115.20M | $157.40M | $133.20M | $1.26B |
Cash & Equivalents | $34.60M | $75.10M | $34.60M | $61.70M |
Free Cash Flow OCF − CapEx | $2.80M | $54.50M | $-10.00M | $-50.20M |
Shares Outstanding | 93.35M | 95.76M | 96.84M | 8.20M |